Effectiveness of influenza vaccine in the community-dwelling elderly

New England Journal of Medicine

Volumn 357, Issue 14, 2007, Pages 1373-1381

  Nichol, Kristin L ^a,b,f   Nordin, James D ^c   Nelson, David B ^a,b   Mullooly, John P ^d   Hak, Eelko ^e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^d KAISER PERMANENTE   (United States)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; COHORT ANALYSIS; EPIDEMIOLOGY; EVALUATION; HOUSING; MORTALITY; RISK; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME; UNITED STATES;

AGED; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); HOSPITALIZATION; HOUSING; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; RISK; TREATMENT OUTCOME; UNITED STATES;

EID: 34948849855     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa070844     Document Type: Article

References (45)

1. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004;292:1333-40.
2. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86.
3. Advisory Committee on Immunization Practices. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55 (RR-10):1-42. [Erratum, MMWR Morb Mortal Wkly Rep 2006;55:800.]
4. Schwartz B, Hinman A, Abramson J, et al. Universal influenza vaccination in the United States: are we ready? Report of a meeting. J Infect Dis 2006;194:Suppl 2:S147-S154.
5. Nichol KL. Influenza vaccination in the elderly: impact on hospitalisation and mortality. Drugs Aging 2005;22:495-515.
6. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005;366:1165-74. [Erratum, Lancet 2006;367:986.]
7. Jacobson RM, Targonski PV, Poland GA. Meta-analyses in vaccinology. Vaccine 2007;25:3153-9.
8. Glezen WP, Simonsen L. Benefits of influenza vaccine in US elderly - new studies raise questions. Int J Epidemiol 2006;35:352-3.
9. Jefferson T. Influenza vaccination: policy versus evidence. BMJ 2006;333:912-5.
10. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84.
11. Nichol KL, Wuorenma J, Von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998;158:1769-76.
12. Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis 2001;184:665-70.
13. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-32.
14. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127:757-63.
15. Hak E, Wei F, Nordin J, Mullooly J, Poblete S, Nichol KL. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis 2004;189:450-8.
16. Hak E, Verheij TJ, Grobbee DE, Nichol KL, Hoes AW. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health 2002;56:951-5.
17. Hak E, Hoes AW, Nordin J, Nichol KL. Benefits of influenza vaccine in US elderly - appreciating issues of confounding bias and precision. Int J Epidemiol 2006;35:800-2.
18. Mayo NE, Nadeau L, Levesque L, Miller S, Poissant L, Tamblyn R. Does the addition of functional status indicators to case-mix adjustment indices improve prediction of hospitalization, institutionalization, and death in the elderly? Med Care 2005;43:1194-202.
19. Jackson LA, Nelson JC, Benson P, et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 2006;35:345-52.
20. Walter LC, Brand RJ, Counsell SR, et al. Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA 2001;285:2987-94.
21. Carey EC, Walter LC, Lindquist K, Covinsky KE. Development and validation of a functional morbidity index to predict mortality in community-dwelling elders. J Gen Intern Med 2004;19:1027-33.
22. Lee SJ, Linkdquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006;295:801-8.
23. Lethbridge-Cejku M, Rose D, Vickerie J. Summary health statistics for US adults: National Health Interview Survey, 2004. Vital and health statistics. Series 10. No. 228. Washington, DC: Government Printing Office, 2006:table 19. (Accessed September 7, 2007, at http://www.cdc.gov/nchs/data/series/sr_10/ sr10_228.pdf.)
24. Lin DY, Psaty BM, Kronmal RA. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 1998;54:948-63.
25. Banthin JS, Taylor AK. Medical Expenditure Panel Survey - research findings #15: HMO enrollment in the United States: estimates based on household reports, 1996. Rockville, MD: Agency for Healthcare Research and Policy. (Accessed September 7, 2007, at http://www.meps.ahrq.gov/mepsweb/data_files/ publications/rf15/rf15.shtml.)
26. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006;24:1159-69.
27. McElhaney JE. The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine 2005;23:Suppl 1:S10-S25.
28. Targonski PV, Jacobson RM, Poland GA. Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine 2007;25:3066-9.
29. Gross PA, Quinnan GV Jr, Weksler ME, Setia U, Douglas RG Jr. Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine 1989;7:303-8.
30. Fulöp T Jr, Wagner JR, Khalil A, Weber J, Trottier L, Payette H. Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects. J Gerontol A Biol Sci Med Sci 1999;54:M59-M64.
31. Jefferson T, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2007;2:CD001269.
32. Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006;355:2513-22.
33. Herrera GA, Iwane MK, Cortese M, et al. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. Vaccine 2007;25:154-60.
34. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995;123:518-27.
35. Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005;165:265-72.
36. Racial/ethnic disparities in influenza and pneumococcal vaccination levels among persons aged > or =65 years - United States, 1989-2001. MMWR Morb Mortal Wkly Rep 2003;52:958-62.
37. Fry AM, Shay DK, Holman RC, Curns AT, Angerson LJ. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA 2005;294:2712-9.
38. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the US: 1990-1998. Diabetes Care 2000;23:1278-83.
39. Morgenstern H. Ecologic studies in epidemiology: concepts, principles, and methods. Annu Rev Public Health 1995;16:61-81.
40. Mac Donald R, Baken L, Nelson A, Nichol KL. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999;16:173-7.
41. King JC, Stoddard JJ, Gaglani M, et al. Effectiveness of school-based influenza vaccination. N Engl J Med 2006;355:2523-32.
42. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with the use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005;23:1540-8.
43. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001;344:889-96.
44. Jordan R, Connock M, Albon E, et al. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine 2006;24:1047-62.
45. Fukuda K, Kieny MP. Different approaches to influenza vaccination. N Engl J Med 2006;355:2586-7.